ATE380545T1 - Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung - Google Patents

Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung

Info

Publication number
ATE380545T1
ATE380545T1 AT03014596T AT03014596T ATE380545T1 AT E380545 T1 ATE380545 T1 AT E380545T1 AT 03014596 T AT03014596 T AT 03014596T AT 03014596 T AT03014596 T AT 03014596T AT E380545 T1 ATE380545 T1 AT E380545T1
Authority
AT
Austria
Prior art keywords
active ingredients
oral administration
pharmaceutical preparation
delayed release
release pharmaceutical
Prior art date
Application number
AT03014596T
Other languages
English (en)
Inventor
Jong-Soo Woo
Moon-Hyuk Chi
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE380545T1 publication Critical patent/ATE380545T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03014596T 2002-10-23 2003-07-08 Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung ATE380545T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020064940A KR100548925B1 (ko) 2002-10-23 2002-10-23 약물의 경구투여용 서방성 조성물

Publications (1)

Publication Number Publication Date
ATE380545T1 true ATE380545T1 (de) 2007-12-15

Family

ID=36093911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03014596T ATE380545T1 (de) 2002-10-23 2003-07-08 Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung

Country Status (19)

Country Link
US (1) US7704526B2 (de)
EP (1) EP1413295B1 (de)
JP (1) JP4177227B2 (de)
KR (1) KR100548925B1 (de)
CN (1) CN100342912C (de)
AT (1) ATE380545T1 (de)
AU (1) AU2003272118B2 (de)
BR (1) BR0315604A (de)
CA (1) CA2502731C (de)
DE (1) DE60317993T2 (de)
ES (1) ES2297078T3 (de)
IL (1) IL167725A (de)
MX (1) MXPA05004018A (de)
NZ (1) NZ539192A (de)
PL (1) PL375440A1 (de)
RU (1) RU2295358C2 (de)
UA (1) UA77123C2 (de)
WO (1) WO2004037290A1 (de)
ZA (1) ZA200503270B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
KR100620241B1 (ko) * 2004-10-21 2006-09-19 한국유나이티드제약 주식회사 벤라팍신 염산염의 장기지속성 경구투여 조성물
WO2006129966A1 (en) * 2005-05-31 2006-12-07 Ctc Bio, Inc. Manufacturing method of controlled-release tablet containing doxazocin mesylate
US9029427B2 (en) * 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
AU2006329819A1 (en) * 2005-12-27 2007-07-05 Monosol Rx Llc pH modulated films for delivery of actives
CN101129355B (zh) * 2007-08-03 2010-12-08 山东华信制药有限公司 一种洛伐他汀缓释片及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
PL226261B1 (pl) * 2008-12-31 2017-07-31 Univ Jagielloński Kompozycja do przedłużonego uwalniania heparyny i zastosowanie żelu alginian-hydroksypropyloceluloza do przedłużonego uwalniania heparyny
WO2013023250A1 (en) 2011-08-16 2013-02-21 Baker Idi Heart & Diabetes Institute Holdings Limited Controlled-release formulation
CN102349880B (zh) * 2011-10-12 2015-07-22 合肥华方医药科技有限公司 伊拉地平控释片及其制备方法
RU2554815C1 (ru) * 2014-06-18 2015-06-27 Общество с ограниченной ответственностью "Нанолек" Гипотензивное средство
KR20170098897A (ko) 2014-12-22 2017-08-30 카디오라 피티와이 엘티디 치료 방법
CN107050419A (zh) * 2017-04-20 2017-08-18 上药东英（江苏）药业有限公司 一种培哚普利及其盐的渗透泵片及其制备方法
EP3501503A1 (de) * 2017-12-22 2019-06-26 Cosmo Technologies Ltd. Feste verabreichungszusammensetzung
CN109288808A (zh) * 2018-11-13 2019-02-01 华东理工大学 一种溶出度高的植物纤维素胶囊

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765984A (en) * 1986-01-22 1988-08-23 Colgate-Palmolive Company Stable single unit dose oral product
US4792452A (en) 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
ATE424810T1 (de) * 1998-12-11 2009-03-15 Nostrum Pharmaceuticals Inc Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
CN1327381A (zh) * 1999-10-20 2001-12-19 帝人株式会社 水性药物组合物
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
AU2001261433A1 (en) * 2000-05-12 2001-11-26 Pharmacia And Upjohn Company Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
US6465014B1 (en) * 2001-03-21 2002-10-15 Isp Investments Inc. pH-dependent sustained release, drug-delivery composition

Also Published As

Publication number Publication date
DE60317993T2 (de) 2008-04-17
CA2502731C (en) 2009-03-17
CA2502731A1 (en) 2004-05-06
JP2004143175A (ja) 2004-05-20
EP1413295A1 (de) 2004-04-28
JP4177227B2 (ja) 2008-11-05
AU2003272118A1 (en) 2004-05-13
NZ539192A (en) 2006-11-30
BR0315604A (pt) 2005-08-23
DE60317993D1 (de) 2008-01-24
EP1413295B1 (de) 2007-12-12
IL167725A (en) 2010-05-31
RU2295358C2 (ru) 2007-03-20
KR20040036130A (ko) 2004-04-30
CN1741819A (zh) 2006-03-01
KR100548925B1 (ko) 2006-02-02
US7704526B2 (en) 2010-04-27
AU2003272118B2 (en) 2007-03-08
CN100342912C (zh) 2007-10-17
ES2297078T3 (es) 2008-05-01
MXPA05004018A (es) 2007-08-30
PL375440A1 (en) 2005-11-28
WO2004037290A1 (en) 2004-05-06
UA77123C2 (en) 2006-10-16
RU2005115483A (ru) 2005-11-20
ZA200503270B (en) 2006-10-25
US20040081693A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
ATE380545T1 (de) Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
ATE450252T1 (de) Arzneimittel-mikroteilchen
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
ATE504288T1 (de) Oros-push-stick für die kontrollierte abgabe von wirkstoffen
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
JP2010518086A5 (de)
DE60124294D1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
ATE541562T1 (de) Ibuprofen-suspension
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
AP2003002763A0 (en) Controlled release formulations for oral administration
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
EA200701409A1 (ru) Новая композиция
HK1079981A1 (en) A pharmaceutical preparation comprising a abacavirand alovudine and use thereof
DE50311479D1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
GEP20063804B (en) Once-a-day oxycodone formulations
MY145885A (en) Controlled release formulations for oral administration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties